Michela Spinelli, Chief Scientific Officer

Michela Spinelli  is Chief Scientific Officer. She was awarded a PhD in Industrial Biotechnology Pharmacogenomics from the University of Milan-Bicocca (Italy) and she gained 15 years’ experience in cancer academic research. From 2009 to 2010 she worked as researcher at Kimmel Cancer Center, Department of Urology (Philadelphia, USA). From 2010 to 2011 she moved as Read more about Michela Spinelli, Chief Scientific Officer[…]

Antonio Francesco Di Naro, PRESIDENT

Antonio Francesco Di Naro is company Founder & President. He graduated in chemistry and pharmaceutical technologies from University of Milan and can boast more than 20 years’ experience in the development of orphan drugs from research to commercialization. During his professional activity he developed two transplantation products (Thymoglobuline and Celsior). He began his career as Read more about <p hidden>1</p>Antonio Francesco Di Naro, PRESIDENT[…]

Enrico Paroni, General Manager ADIENNE Pharma & Biotech (Switzerland)

Enrico Paroni is ADIENNE Pharma & Biotech SA General Manager. He graduated in chemistry and pharmaceutical technologies from University of Trieste (Italy) . He can claim  more than 15 years’ experience in the formulation, process development and manufacturing of liquid and lyophilized injectable products. He began his carrier in 2003 at AstraZeneca (Italy) where he Read more about Enrico Paroni, General Manager ADIENNE Pharma & Biotech (Switzerland)[…]

Francesc Corpas Lara, Chief Commercial Officer

Francesc Corpas Lara  is ADIENNE’s Chief Commercial Officer. He began his career at Parke Davis and later at Aventis Spain where he developed several projects; the latest project was developed in the area of pharmaceuticals for severe and rare diseases. He also held several executive positions at SangStat Spain SL, an US biopharmaceutical company listed Read more about Francesc Corpas Lara, Chief Commercial Officer[…]

Marco Sardella, Chief Pharmacovigilance Officer

Marco Sardella joined the company in 2015. He is Chief Pharmacovigilance Officer and European Qualified Person for Pharmacovigilance (EEA QPPV) of ADIENNE. In this role, he is globally responsible for the safety of products under investigation and/or available on the markets. He leads the Pharmacovigilance and Risk Management teams. He graduated in Pharmaceutical Chemistry and Read more about Marco Sardella, Chief Pharmacovigilance Officer[…]

Silvia Nosari, Chief Regulatory Affairs Officer

Silvia Nosari (born in 1981) is ADIENNE’s Chief Regulatory Affairs Officer. She graduated from the University of Milan (Italy) in Industrial Biotechnology Pharmacogenomics. Afterwards, she joined the Milan-based Istituto Mario Negri as research scientist, conducting genetic research in the field of rare diseases. She joined the company in 2006 as R&D Manager and is heading Read more about Silvia Nosari, Chief Regulatory Affairs Officer[…]

Federico Sanvito, Chief Manufacturing Officer and General Manager ADIENNE SRL (Italy)

Federico Sanvito is Chief Manufacturing Officer and is also in charge as General Manager for Italy. He graduated in Engineering from Politecnico of Milan and can boast more than 20 years experience in pharmaceutical manufacturing, having worked as well as Engineering Director at Bausch & Lomb and as Engineering Manager at AstraZeneca. He joined ADIENNE Read more about Federico Sanvito, Chief Manufacturing Officer and General Manager ADIENNE SRL (Italy)[…]